WebBiontech Se (NASDAQ: BNTX) is owned by 16.46% institutional shareholders, 0.00% Biontech Se insiders, and 83.54% retail investors. Baillie Gifford Co is the largest individual Biontech Se shareholder, owning 7.72M shares representing 3.20% of the company. Baillie Gifford Co's Biontech Se shares are currently valued at $985.68M. WebMar 30, 2024 · The billionaire Struengmann family behind COVID-19 vaccine maker BioNTech is in talks to take a stake in German diagnostics firm Munich Leukemia Laboratory (MLL) as it seeks to add investments in ...
BioNTech SE (BNTX) Stock Major Holders - Yahoo Finance
WebBNTX 150.09 +4.42 +3.03% : BioNTech SE - MSN Money. BNTX. Nasdaq Stock Market • NLS real time price. • CURRENCY IN USD. • Biotechnology & Medical Research. WebMar 6, 2024 · Pfizer, which splits costs and profit margins equally with BioNTech, expects $15bn in 2024 sales based on current deals. The final number could be twice as high, as … how much money do fake news sites make
Vietnam Medical Device Registration (2024) - benazit.com
WebApr 11, 2024 · Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19. The brothers cofounded generic drugmaker Hexal ... WebMar 28, 2024 · Maybe BioNTech owners are viewing bivalent doses sold in the US and concluding that the only uptake for their toxic injections is in places where political or university campus mandates exist. Onwards! Please subscribe, or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. ... WebMar 14, 2024 · Jasmina Alatovic. Vice President Corporate Communications. +49 (0)6131 9084-1513. Send e-mail. how much money do engineers make a year